Welcome to our dedicated page for Barrick Mining news (Ticker: B), a resource for investors and traders seeking the latest updates and insights on Barrick Mining stock.
Barrick Mining Corporation reports developments tied to its global gold and copper mining, exploration and development portfolio. Company news commonly covers operating and financial results, mine and project updates, technical and governance matters, and capital allocation actions for common shares that trade on the NYSE under B and on the TSX under ABX.
Recurring updates include quarterly results releases, dividend declarations, share repurchase authorizations, annual meeting materials and changes in executive or board oversight. Barrick also reports on its gold assets in North America and other mining jurisdictions, including disclosures connected to major mines, development projects, reserves, production, costs, cash flow and responsible mining obligations.
Barrick (NYSE:B) welcomed the Ontario Court of Appeal's April 8, 2026 dismissal of an appeal by Tanzanian residents related to alleged human rights incidents near the North Mara gold mine. The appeal upheld a Superior Court ruling that Ontario is not the proper forum and the matters must be adjudicated in Tanzania.
Evidence in the proceedings reportedly showed the Tanzanian Police Force acted independently of Barrick, and the company reiterated a zero tolerance policy for human rights violations by employees, contractors or third parties.
Barrick (NYSE:B) provided an update on the Reko Diq project on April 2, 2026, saying it will slow development and continue a comprehensive review until mid-2027 due to escalating security risks in Pakistan and the region.
The company approved development of Phase 1 with reduced capital spend, said it will continue local community programs, and warned of possible significant increases to the previously disclosed capital costs and timeline. Previously disclosed Phase 1 capital was $5.6–$6.0 billion (100% basis) and Phase 2 $3.3–$3.6 billion, with first production targeted by end of 2028.
Crawford & Company (NYSE: A) named Jemin Thakkar global chief information officer, effective April 1, 2026. Thakkar will report to President & CEO Bruce Swain and lead Crawford’s global IT and technology organization, expanding his prior role as chief information security officer.
The reorganization centralizes IT governance, aims to improve data integration and analytics, clarify accountability for technology investments, accelerate enterprise modernization, and responsibly advance AI with disciplined data and security practices.
Cereno Scientific (NASDAQ First North: B) reported initial 12-month Expanded Access Program (EAP) learnings for lead candidate CS1 in pulmonary arterial hypertension (PAH). The EAP enrolled 10 patients; CS1 was well tolerated with no unexpected safety concerns or deaths, and no discontinuations reported as related to CS1.
Six of ten patients completed 12 months; two discontinued after atrial fibrillation events assessed as not related, one withdrew consent and one was lost to follow-up. Phase IIa (25 patients, 3 months) met primary safety and tolerability endpoint with no drug-related serious adverse events. Phase IIb enrollment anticipated June 2026; further EAP analyses due Q2 2026.
BioArctic (Nasdaq: B) announces the Nomination Committee's proposals for the Annual General Meeting on May 28, 2026. The committee proposes an eight-member board, re-electing Eugen Steiner as chair and six existing members, and adding Philip Scheltens and Linda Nilsson as new board members.
Pär Gellerfors has declined re-election; Linda Nilsson is proposed to represent the Gellerfors family's holding company. The Nomination Committee members represent ~57% of shares and ~83% of votes.
Hexagon (B) will propose a distribution and listing of Octave Intelligence plc at its AGM on 24 April 2026, where ten Hexagon shares entitle holders to one Octave share. Octave Class B shares are expected to list on Nasdaq New York, with SDRs listed on Nasdaq Stockholm for about two years.
An indicative timetable sets the record date for the distribution on 22 May 2026 and first NY trading on 28 May 2026. Octave will file an amended Form 10 and host an Investor Day on 26 March 2026.
Crawford & Company (NYSE:A) named W. Bruce Swain Jr. president and chief executive officer, effective immediately on March 23, 2026.
Swain served as interim CEO since January 1, 2026, has more than three decades at Crawford including 19 years as CFO, and will remain on the board. Jesse Crawford Sr. will not stand for reelection at the Annual Shareholder Meeting on May 14, 2026, and will become an honorary board member and emeritus officer after the ASM.
BioArctic (NASDAQ: B) reported new data presented at AD/PD 2026 on long-term, real-world IV lecanemab treatment persistence and additional company presentations. Real-world claims analysis showed 78.4% persistence at 18 months, 71.7% at 20 months and 67.3% at 24 months. BioArctic also presented data on lecanemab binding to soluble Aβ protofibrils and a poster on exidavnemab trial screening using alpha-synuclein SAA. The release notes investigational status and no guarantee of regulatory approval.
Cereno Scientific (NASDAQ: B) received Swedish Medical Products Agency approval to start a Phase I pharmacokinetic study of CS014, designed using FDA pre-IND feedback. The open-label, randomized, two-period crossover trial in 14 healthy adults compares seven-day repeat dosing of CS014 versus valproic acid to characterize total and unbound plasma concentrations at steady state.
The company says a successful PK study could remove the need for additional nonclinical safety work and a Phase IIa trial, supporting a capital-efficient path toward a planned Phase II study in PH-ILD in Q1 2027. Results are expected mid-2026.
Contractor Connection (NYSE:A) announced a strategic partnership with Helixco to integrate Helixco’s time-and-materials validation platform into Contractor Connection’s commercial managed repair program. The partnership aims to add real-time transparency, standardized workflows, auditable documentation and improved billing accuracy across commercial repair projects.
The collaboration pairs Helixco’s validation technology with Contractor Connection’s credentialed contractor network to support consistency, accountability and more predictable commercial repair outcomes for carrier partners and contractors.